4Cazzola M,Matera MG,Lotvall J. Ultra longacting 132-agonists in development for asthma and chronic obstructive pulmonary disease [J]. Expert Opin Investig Drugs, 2005,14 : 775-783. 被引量：1
7Mark Fitz Gerald. Global initiative for asthma ( 2012 ) [DB/ OL]. http://www.ginasthma.org, 2012. 被引量：1
8Wong GW, Kwon N, Hong JG. Pediatric asthma control in Asia: phase 2 of the asthma insights and reaality in Asia-Pacific (AIRIAP 2 ) survey [J]. Allegy, 2013, 68 (4) : 524-530. 被引量：1
9Chrystyn H, Small M, Milligan G. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD [J]. Respir Med, 2014, 108 ( 2 ) : 358-365. 被引量：1
10Voshaar T, Spinola M, Linnane P. Comparing usability of NEXThaler with other inhaled corticosteroid/long-acting fl2- agonist fixed combination dry powder inhalers in asthma pa- tients [J]. Aerosol Med Pulm Drug Deliv, 2013, 12: 3. 被引量：1
